- Sections
- C - Chimiemétallurgie
- C08L - Compositions contenant des composés macromoléculaires
- C08L 5/04 - Acide alginiqueSes dérivés
Détention brevets de la classe C08L 5/04
Brevets de cette classe: 500
Historique des publications depuis 10 ans
|
22
|
38
|
42
|
30
|
46
|
39
|
39
|
57
|
42
|
9
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Board of Regents, The University of Texas System | 5989 |
13 |
| Case Western Reserve University | 1857 |
10 |
| Sigilon Therapeutics, Inc. | 108 |
10 |
| President and Fellows of Harvard College | 6049 |
7 |
| Northwestern University | 3483 |
7 |
| Mochida Pharmaceutical Co., Ltd. | 339 |
7 |
| The Regents of the University of California | 20355 |
5 |
| Centre National de La Recherche Scientifique | 10801 |
5 |
| Drexel University | 1013 |
5 |
| Nisshinbo Holdings Inc. | 374 |
5 |
| The General Hospital Corporation | 4793 |
4 |
| Agency for Science, Technology and Research | 3665 |
4 |
| Allergan Pharmaceuticals International Limited | 229 |
4 |
| Norwegian University of Science and Technology (ntnu) | 187 |
4 |
| Nordovo Biosciences AS | 6 |
4 |
| Tazuke Kofukai | 7 |
4 |
| HCS Innovation LLC | 6 |
4 |
| Sway Innovation Co. | 12 |
4 |
| Massachusetts Institute of Technology | 10181 |
3 |
| Academisch Ziekenhuis Maastricht | 193 |
3 |
| Autres propriétaires | 388 |